JHJAX
Price
$25.07
Change
-$0.12 (-0.48%)
Updated
Sep 20 closing price
VTSMX
Price
$136.92
Change
-$0.33 (-0.24%)
Updated
Sep 20 closing price
Ad is loading...

JHJAX vs VTSMX

Header iconJHJAX vs VTSMX Comparison
Open Charts JHJAX vs VTSMXBanner chart's image
JHancock ESG Large Cap Core A
Price$25.07
Change-$0.12 (-0.48%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx I
Price$136.92
Change-$0.33 (-0.24%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JHJAX vs VTSMX Comparison Chart
Loading...
VS
JHJAX vs. VTSMX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JHJAX is a Buy and VTSMX is a Buy.

FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.72T vs. JHJAX (148M). VTSMX pays higher dividends than JHJAX: VTSMX (1.26) vs JHJAX (0.48). JHJAX was incepted earlier than VTSMX: JHJAX (8 years) vs VTSMX (32 years). JHJAX is a more actively managed with annual turnover of: 12.00 vs. VTSMX (2.00). JHJAX has a lower initial minimum investment than VTSMX: JHJAX (1000) vs VTSMX (3000). JHJAX (26.59) and VTSMX (25.89) have marching annual gain over last year. VTSMX return over 5 years is better than : 82.93 vs. JHJAX (73.98).
JHJAXVTSMXJHJAX / VTSMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years32 years-
Gain YTD16.57316.88498%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets148M1.72T0%
Annual Yield % from dividends0.481.2638%
Returns for 1 year26.5925.89103%
Returns for 3 years16.9321.3379%
Returns for 5 years73.9882.9389%
Returns for 10 yearsN/A178.97-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVVE5.040.80
+18.87%
Nuvve Holding Corp
TR32.400.19
+0.59%
Tootsie Roll Industries
CEVA23.03-0.23
-0.99%
CEVA
TTC85.38-0.98
-1.13%
Toro Company (The)
PIII0.46-0.03
-5.37%
P3 Health Partners